-
Singapore eDevelopment subsidiary starts advanced research on Linebacker
pharmaceutical-technology
May 27, 2017
Singapore eDevelopment subsidiary Global BioLife has started advanced research on a new universal therapeutic drug platform called Linebacker to tackle multiple conditions such as Alzheimer's, diabetes, and cancer.
-
AC Immune and Essex to develop biological treatment for neurodegenerative diseases
pharmaceutical-technology
May 27, 2017
AC Immune and Essex Bio-Technology have signed a research collaboration agreement to conduct a pre-clinical study and clinical codevelopment of a novel biological therapeutic to treat neurodegenerative diseases and neuroinflammation.
-
FDA approves Sanofi and Regeneron’s Kevzara for adult rheumatoid arthritis
pharmaceutical-technology
May 27, 2017
Sanofi and Regeneron Pharmaceuticals’ drug Kevzara (sarilumab) has received the US Food and Drug Administration (FDA) approval to treat adult patients affected with moderately to severely active rheumatoid arthritis (RA).
-
Ardelyx’s first-in-class NHE3 blocker Tenapanor boasts positive phase III data
pharmaceutical-technology
May 27, 2017
On May 12, Ardelyx announced positive top-line results from the T3MPO-1 Phase III study for the use of tenapanor to treat patients with constipation predominant Irritable Bowel Syndrome (IBS-C).
-
UK CMA accuses Merck of breaking competition law with discount scheme
pharmaceutical-technology
May 27, 2017
The UK Competition and Markets Authority (CMA) has accused US pharmaceutical company Merck Sharp & Dohme (MSD) of operating an anti-competitive discount scheme for its medicine Remicade.
-
Unisys unveils PharmaTrack software to manage global pharmaceutical supply chain
pharmaceutical-technology
May 27, 2017
Global information technology company Unisys has launched a new software to provide enhanced visibility and management of the entire pharmaceutical supply chain worldwide.
-
FDA approves Sun Pharma’s tildrakizumab for moderate-to-severe plaque psoriasis
pharmaceutical-technology
May 27, 2017
Indian company Sun Pharmaceutical Industries has received the US Food and Drug Administration (FDA) approval of the Biologics License Application (BLA) for tildrakizumab to treat patients with moderate-to-severe plaque psoriasis.
-
Bioverativ to purchase True North Therapeutics for $400m
pharmaceutical-technology
May 27, 2017
Global biotechnology company Bioverativ has entered a definitive agreement to acquire US-based company True North Therapeutics for $400m.
-
Evotec Opens U.S. HQ in NJ
contractpharma
May 27, 2017
Also unveils 20,000 square-foot facility expansion
-
Recipharm Makes Appointment in the UK & Ireland
contractpharma
May 27, 2017
Recipharm has invested in its UK and Ireland presence with the appointment of Shabbir Mostafa to its business management team.